Skip to main content
3SBio Inc. logo

3SBio Inc. — Investor Relations & Filings

Ticker · 1530 ISIN · KYG8875G1029 LEI · 529900P0TQC1E9Y7FN31 HKEX Manufacturing
Open in API
Filings indexed 1,491 across all filing types
Latest filing 2020-04-29 Annual Report
Country KY Cayman Islands
Listing HKEX 1530

About 3SBio Inc.

http://www.3sbio.com

3SBio Inc. is a biopharmaceutical enterprise specializing in the integrated research, development, production, and commercialization of innovative biopharmaceutical products. The company operates as a biotechnology firm, focusing on the discovery, development, manufacture, and marketing of biologics, with a particular emphasis on mammalian cell-based biopharmaceuticals. 3SBio addresses critical medical needs by providing an extensive range of products and services to markets both domestically and internationally.

Recent filings

Filing Released Lang Actions
2019 ANNUAL REPORT
Annual Report Classification · 100% confidence The document is titled '2019 Annual Report' and contains detailed sections typical of an annual report, including Company Profile, Corporate Information, Financial Highlights, Chairman's Statement, Management Discussion and Analysis, Directors and Senior Management, Report of Directors, Corporate Governance Report, Independent Auditor's Report, Consolidated Financial Statements, and Notes to Financial Statements. It also includes an Environmental, Social and Governance Report annex. The length is substantial (15,000 characters), indicating it is the full report rather than a brief announcement. The content covers comprehensive financial performance, business overview, management discussion, and audited financial statements for the fiscal year ended 31 December 2019. Therefore, this document fits the definition of an Annual Report (10-K). FY 2019
2020-04-29 English
VOLUNTARY ANNOUNCEMENT - APPOINTMENT OF CHIEF FINANCIAL OFFICER
Board/Management Information Classification · 100% confidence The document is a voluntary announcement from 3SBio Inc. regarding the appointment of a new Chief Financial Officer, Mr. Wang Fei. It provides biographical details and the effective date of the appointment. There is no financial data, report, or regulatory filing referenced beyond the announcement itself. The content clearly relates to a change in senior management. According to the filing definitions, announcements of changes in the company's board of directors or senior management fall under Board/Management Information (MANG). The document length is short and it is not a report or certification, so it is not an Annual Report, Interim Report, or Regulatory Filing. Therefore, the correct classification is MANG.
2020-04-27 English
VOLUNTARY ANNOUNCEMENT REPURCHASE OF EUR300,000,000 ZERO COUPON CONVERTIBLE BONDS DUE 2022
Capital/Financing Update Classification · 100% confidence The document is a voluntary announcement by 3SBio Inc. regarding the repurchase of €5,000,000 principal amount of zero coupon convertible bonds due 2022. It discusses the bond repurchase transaction details, the impact on the company's financial position, and potential future repurchases. The document is relatively short (4159 characters) and focuses on a specific financing activity rather than a full financial report or earnings release. There is no detailed financial statement or comprehensive analysis, nor is it a regulatory certification or voting result. The content clearly fits the category of a Capital/Financing Update, as it provides an update on the company's bond repurchase and capital structure changes.
2020-04-20 English
Next Day Disclosure Return
Share Issue/Capital Change Classification · 100% confidence The document is a Next Day Disclosure Return for a Main Board listed issuer, 3SBio Inc., detailing changes in issued share capital and share buybacks. It includes specifics about convertible bonds issued, repurchases of bonds, and confirmations related to compliance with listing rules. The content focuses on reporting changes in capital structure and share repurchases, with detailed tables and confirmations. This matches the description of a Share Issue/Capital Change filing, which covers announcements regarding new share issues, stock splits, or other capital changes. The document is not a full financial report, audit, or earnings release, nor is it a simple announcement of a report. Therefore, the appropriate classification is Share Issue/Capital Change (SHA).
2020-04-19 English
Next Day Disclosure Return
Transaction in Own Shares Classification · 95% confidence The document is a disclosure return related to changes in issued share capital and share buybacks by 3SBio Inc., specifically detailing repurchases of convertible bonds and related share capital changes. It references compliance with listing rules and provides detailed transactional data on bond repurchases and share capital changes. The document is regulatory in nature, reporting specific capital changes and repurchase activities, but it is not a full financial report, earnings release, or management discussion. It is not a report publication announcement since it contains substantive data and confirmations. The content fits best under the category of Transaction in Own Shares (POS), as it reports on the company's repurchase of its own convertible bonds and related share capital changes.
2020-04-17 English
Monthly Return of Equity Issuer on Movements in Securities for the Month Ended 31 March 2020
Share Issue/Capital Change Classification · 95% confidence The document is titled 'Monthly Return of Equity Issuer on Movements in Securities' for the month ended 31/03/2020, submitted to the Hong Kong Exchanges and Clearing Limited. It details movements in authorised share capital, issued share capital, share options, warrants, convertibles, and other share-related transactions. The content focuses on changes in share capital, share issuance, repurchases, and related corporate actions. There is no indication of financial performance data, earnings, management discussion, or audit information. The document is a regulatory filing reporting share capital movements to the exchange, consistent with capital/financing updates or share capital changes. Given the detailed nature of share capital movements and the focus on equity issuance and repurchases, the most appropriate classification is Share Issue/Capital Change (SHA). The document length and detail confirm it is not a brief announcement but a substantive report on capital changes.
2020-04-03 English

Browse filings by year

28 years

Report missing filing

Can't find a specific document? Let us know and we'll add it within 24 hours.

We will notify you once the filing is added.
Report sent
Thank you. We will check the data and update it shortly.